David Tribble


Department of Primary Appointment:
School of Medicine
Preventive Medicine and Biostatistics
Vice Chair of Research, PMB; Science Director, Infectious Disease Clinical Research Program
Location: Uniformed Services University of the Health Sciences, Bethesda, MD
Research Interests:
Infectious Diseases
Travel medicine
Office Phone


Biology (BA), Hendrix College, Conway, AR
Medicine (MD), University of Arkansas College of Medicine, Little Rock, AR
Public health (MPH and DrPH), Uniformed Services University (USU), Bethesda, MD
Internal Medicine, Naval Hospital Portsmouth, Portsmouth, VA
Infectious Diseases, National Naval Medical Center, Bethesda, MD


Dr. Tribble completed his medical training at the University of Arkansas for Medical Sciences followed by Internal Medicine residency at the Naval Hospital Portsmouth, Infectious Diseases fellowship at the National Naval Medical Center (NNMC), and a Doctorate in Public Health at the Uniformed Services University of the Health Sciences (USU). After assignments at the Naval Medical Research Unit No. 3 in Cairo, Egypt, NNMC Infectious Diseases Division, and the Enteric Diseases Department, Naval Medical Research Center, Dr. Tribble joined the faculty at USU to establish the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense and National Institute of Allergy and Infectious Disease (NIAID)/National Institutes of Health (NIH) collaborative research program. As IDCRP Science Director, Dr. Tribble provides senior leadership for strategic planning and clinical research. Dr. Tribble’s areas of research focus include trauma-related infectious complications, SSTI epidemiology and S. aureus infection prevention strategies, deployment/travel-associated infection epidemiology and clinical management. Dr. Tribble has also had longstanding research efforts in the field of bacterial diarrheal disease vaccine development including development and investigation of experimental infection models in volunteers, with particular emphasis on Campylobacter jejuni.


Tribble DR et al. Travelers’ Diarrhea in Thailand: Randomized, Double-Blind Trial Comparing Azithromycin-Based Regimens (Single Dose and 3-Day) versus Levofloxacin (3-Day). Clin Infect Dis 2007; 44(1):338-346.

Tribble DR et al. Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a Campylobacter hyperendemic region. J Clin Microbiol. 2008 Apr; 46(4):1418-25.

Tribble DR et al. Campylobacter jejuni Experimental Infection in Humans: Assessment of Duration of Protection. Infect Immun 2010 Apr; 78(4):1750-9.

Tribble DR et al. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin Infect Dis 2009 Nov 15; 49(10):1512-9.

Tribble D et al. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine. 2010 Aug 23; 28(37):6076-85.

Tribble DR et al. Infection-Associated Clinical Outcomes in Hospitalized Medical Evacuees following Traumatic Injury- Trauma Infectious Disease Outcome Study (TIDOS). J Trauma. 2011 Jul; 71(1 Suppl):S33-42.

Warkentien T et al for the IDCRP TIDOS group. Invasive Mold Infections following Combat-related Injuries. Clin Infect Dis 2012 Dec;55(11):1441-1449.

Tribble DR et al and the IDCRP TIDOS Group. Epidemiology of Trauma-related Infections among a Combat Casualty Cohort Following Initial Hospitalization: The Trauma Infectious Disease Outcomes Study. Surgical Infections. 2018 Jul;19(5):494-503.

Riddle MS et al and the TrEAT TD Study Team. Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: a randomized controlled trial comparing three single dose antibiotic regimens with loperamide. Clin Infect Dis. 2017 Nov 29;65(12):2008-2017.

Ellis MW et al. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a cluster-randomized controlled trial among high-risk military trainees. Clin Infect Dis. 2014 Jun;58(11):1540-8.